Table: Rohto -2024/25 parent results

Rohto Pharmaceutical

13/05/2025 07:34

May 13 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            136.56          128.94                                
                 (+5.9 pct)      (+11.8 pct)                             
  Operating         20.03           21.43                                
                 (-6.6 pct)      (+15.2 pct)                             
  Recurring         22.68           26.70                                
                 (-15.0 pct)     (+18.9 pct)                             
  Net               18.86           19.97                                
                 (-5.6 pct)      (+20.5 pct)                             
  EPS             82.79 yen       87.54 yen                              
  EPS Diluted     82.38 yen       87.28 yen                              
  Ann Div         36.00 yen       27.00 yen      42.00 yen               
  -Q2 Div         16.00 yen       12.00 yen      21.00 yen               
  -Q4 Div         20.00 yen       15.00 yen      21.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T